|
Sunflower Sprout: Nutraceuticals for Metabolic Syndrome |
|---|---|
| รหัสดีโอไอ | |
| Creator | Catthareeya Sukwan |
| Title | Sunflower Sprout: Nutraceuticals for Metabolic Syndrome |
| Contributor | Varavut Tanamool, Suthida Chanlun, Pittaya Papirom |
| Publisher | คณะเทคโนโลยีการเกษตร มหาวิทยาลัยราชภัฏมหาสารคาม |
| Publication Year | 2562 |
| Journal Title | วารสารเกษตรพระวรุณ |
| Journal Vol. | 16 |
| Journal No. | 2 |
| Page no. | 415 -426 |
| Keyword | Sunflower sprout, Metabolic syndrome, LipidandGlucose |
| URL Website | https://li01.tci-thaijo.org/index.php/pajrmu/index |
| Website title | วารสารเกษตรพระวรุณ |
| ISSN | 1685-8379 |
| Abstract | The purpose of this study was to evaluate the efficacy of sunflower sprout (SFS) as potential nutraceutical for metabolic syndromein mice. The micewere divided into 6 groups of 5 each: Low fat diet (LF), Reference diet (RD), High fat diet (HF), HF containing SFS in the amount of 2% (HF+SFS2%), 8% (HF+SFS8%) and 16% (HF+SFS16%), respectively. Theexperiment revealedthe most significant bodyweight increase of 5.56 +0.10%(P<0.05). Various servings of SFS (2%, 8% and 16%) did not affect theplasma triglyceride level (P>0.05), whereas the SFS did significantly decreased the total cholesterol level (P<0.05).The experiment also resulted in a rise of HDL and a reduction of LDL in the LF group and the HF groups that received SFS(2%, 8%, and 16% SFS). Hence, a significant decrease of TC:HDL ratio was observedin these4 mentionedgroups when comparedto the HF group that did not receive SFS (P<0.05). The fasting blood glucose levels observedin the HF groups thatwere fed with complete doses of SFS had comparable value to the LF group. Additionally, liver enzymes (SGOT and ALP) were observedto be on the physiological range of healthy mice, which indicatesSFS does not exhibit any sign of adverse effect on the liver function orgeneral health. This outcome suggests the supplementation of SFS ofat least 2% in feed canbenefit thecirculating lipid and glucose levels. |
